Jian Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jian Zheng has a total of 280 co-authors. Here are the top co-authors by number of shared publications:
- Yifeng Zhou
Department of Genetics, Medical College of Soochow University, Suzhou, China
66 shared publications - Binbin Guo
Department of Genetics, School of Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou, China
65 shared publications - Fanrong Li
Department of Genetics, Medical College of Soochow University, Suzhou, Jiangsu, China
65 shared publications - Jiachun Lu
School of public health, Guangzhou medical university, Guangzhou, China
65 shared publications - Jieqiong Deng
Department of Genetics, Medical College of Soochow University, Suzhou, Jiangsu, China
65 shared publications - Jieyu Wang
Department of Genetics, Medical College of Soochow University, Suzhou, Jiangsu, China
65 shared publications
Latest Publications
- 9 November 2026
- Published by Springer Nature in Nature Immunology
- p. 1-13
Mechanosensitive YAP–RUNX1 signaling drives TH1 cell dysfunction and tumor immunosuppression
Tissue stiffening is a predominant malignant physical alteration in cancer progression, yet its effect on specific immune subsets within the tumor microenvironment is not well defined. Here we show that elevated tissue stiffness subverts tumor-infiltrating type 1 helper T (TH1) cells to drive immunosuppression in pancreatic cancer. Mechanistically, stiffness triggers integrin-mediated mechanotransduction to activate YAP, which translocates to the nucleus and cooperates with RUNX1 to transcriptionally upregulate a set of dysfunction-associated genes. These reprogrammed TH1 cells acquire a distinct dysfunction-associated secretory phenotype, which in turn drives M2-like polarization of macrophages and amplifies local immunosuppression. Notably, inhibiting YAP expression or disrupting YAP–RUNX1 interaction reverses the dysfunctional state of TH1 cells and restores antitumor immunity. These findings delineate a mechano–immunological mechanism by which tumor stiffness subverts TH1 cell functions, indicating a possible therapeutic avenue to alleviate immunosuppression and potentiate immunotherapy efficacy in stiff tumors.
- 9 November 2026
- Published by Springer Nature in Nature Immunology
- p. 1-13
Mechanosensitive YAP–RUNX1 signaling drives TH1 cell dysfunction and tumor immunosuppression
Tissue stiffening is a predominant malignant physical alteration in cancer progression, yet its effect on specific immune subsets within the tumor microenvironment is not well defined. Here we show that elevated tissue stiffness subverts tumor-infiltrating type 1 helper T (TH1) cells to drive immunosuppression in pancreatic cancer. Mechanistically, stiffness triggers integrin-mediated mechanotransduction to activate YAP, which translocates to the nucleus and cooperates with RUNX1 to transcriptionally upregulate a set of dysfunction-associated genes. These reprogrammed TH1 cells acquire a distinct dysfunction-associated secretory phenotype, which in turn drives M2-like polarization of macrophages and amplifies local immunosuppression. Notably, inhibiting YAP expression or disrupting YAP–RUNX1 interaction reverses the dysfunctional state of TH1 cells and restores antitumor immunity. These findings delineate a mechano–immunological mechanism by which tumor stiffness subverts TH1 cell functions, indicating a possible therapeutic avenue to alleviate immunosuppression and potentiate immunotherapy efficacy in stiff tumors.